Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cocoon Holdings Limited Regulatory Filings 2016

Jul 12, 2016

49210_rns_2016-07-12_fb0433d1-5a5a-4da9-a38c-6d0c6b69deab.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [109 x 45] intentionally omitted <==

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED 阿里健康信息技術有限公司

(Incorporated in Bermuda with limited liability)

(Stock code: 00241)

FURTHER DELAY IN DISPATCH OF CIRCULAR REGARDING NON-EXEMPT CONTINUING CONNECTED TRANSACTION – SERVICES AGREEMENT

We refer to the announcement of Alibaba Health Information Technology Limited (the “ Company ”) dated April 1, 2016 in relation to, among other things, the non-exempt continuing connected transactions contemplated under the services agreement (the “ Services Agreement ”) entered into between Alibaba Health Technology (Beijing) Company Limited, a wholly owned subsidiary of the Company, and the Tmall Entities on April 1, 2016, and the announcements of the Company dated April 25, May 25, and June 24, 2016, respectively, in relation to the delay in dispatch of the Circular (collectively, the “ Announcements ”). Unless otherwise defined, capitalized terms used in this announcement shall have the same meanings as those defined in the Announcements.

As disclosed in the Announcement dated June 24, 2016, the date of despatch of the Circular has been postponed to a date on or around July 12, 2016. However, the Company requires more time as originally envisaged to finalize the Circular, including but not limited to the letter from the Independent Financial Adviser. The Company currently expects that the despatch date of the Circular will be further delayed to a date on or around August 12, 2016.

By Order of the Board ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED WANG Lei Chief Executive Officer and Executive Director

Hong Kong, July 12, 2016

As at the date of this announcement, the Board comprises nine Directors, of which (i) two are executive Directors, namely, Ms. CHEN Xiao Ying and Mr. WANG Lei; (ii) four are nonexecutive Directors, namely, Mr. WU Yongming, Mr. TSAI Chung, Joseph, Ms. HUANG Aizhu and Mr. KANG Kai; and (iii) three are independent non-executive Directors, namely Mr. YAN Xuan, Mr. LUO Tong and Mr. WONG King On, Samuel.